GALNT12 suppresses the bone-specific prostate cancer metastasis by activating BMP pathway via the O-glycosylation of BMPR1A.

MLA

Yang Yang, et al. “GALNT12 Suppresses the Bone-Specific Prostate Cancer Metastasis by Activating BMP Pathway via the O-Glycosylation of BMPR1A.” International Journal of Biological Sciences, vol. 20, no. 4, Mar. 2024, pp. 1297–313. EBSCOhost, https://doi.org/10.7150/ijbs.91925.

APA

Yang Yang, Meng Ding, Haoli Yin, Wei Chen, Hongwei Shen, Wenli Diao, Lin Yang, Haixiang Qin, Weidong Gan, Xuefeng Qiu, & Hongqian Guo. (2024). GALNT12 suppresses the bone-specific prostate cancer metastasis by activating BMP pathway via the O-glycosylation of BMPR1A. International Journal of Biological Sciences, 20(4), 1297–1313. https://doi.org/10.7150/ijbs.91925

Chicago

Yang Yang, Meng Ding, Haoli Yin, Wei Chen, Hongwei Shen, Wenli Diao, Lin Yang, et al. 2024. “GALNT12 Suppresses the Bone-Specific Prostate Cancer Metastasis by Activating BMP Pathway via the O-Glycosylation of BMPR1A.” International Journal of Biological Sciences 20 (4): 1297–1313. doi:10.7150/ijbs.91925.